The connection between Camp Lejeune and leukemia is well-documented and scientifically supported. Between 1953 and 1987, up to one million people — Marines, Navy personnel, civilian workers, and their families — were exposed to drinking water contaminated with toxic chemicals at this North Carolina military base. Multiple federal studies, including research from the Agency for Toxic Substances and Disease Registry (ATSDR), have confirmed that this exposure is associated with significantly elevated rates of leukemia and other blood cancers.
If you served or lived at Camp Lejeune during those years and have been diagnosed with leukemia, you’re not imagining things and you’re not alone. The U.S. government has formally acknowledged this link through the Camp Lejeune Justice Act of 2022, which allows affected individuals to file claims for compensation. Here’s what you need to know about the science, the symptoms, and your next steps.
What Contaminated the Water at Camp Lejeune?
The drinking water at Camp Lejeune was contaminated by volatile organic compounds (VOCs) that seeped into the groundwater from leaking underground storage tanks, industrial spills, and an off-base dry cleaning operation. Two water treatment plants — Tarawa Terrace and Hadnot Point — supplied water with toxin levels that far exceeded safe limits.
| Contaminant | Source | Peak Level Detected | EPA Safe Limit | Known Cancer Link |
|---|---|---|---|---|
| Trichloroethylene (TCE) | Metal degreasing operations | 1,400 ppb | 5 ppb | Kidney cancer, NHL, leukemia |
| Perchloroethylene (PCE) | Off-base dry cleaner (ABC One-Hour Cleaners) | 215 ppb | 5 ppb | Bladder cancer, NHL, leukemia |
| Benzene | Fuel leaks from underground tanks | 380 ppb | 5 ppb | AML, ALL, other leukemias |
| Vinyl chloride | Degradation of TCE in groundwater | 67 ppb | 2 ppb | Liver cancer, leukemia |
To put those numbers in perspective: TCE levels at Hadnot Point were detected at 280 times the EPA’s maximum contaminant level. People weren’t just drinking this water — they were bathing in it, cooking with it, and using it in swimming pools on base.
How These Chemicals Cause Leukemia
Benzene is the most directly leukemogenic chemical found in Camp Lejeune’s water. It’s classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC), meaning there’s sufficient evidence it causes cancer in humans. Benzene damages bone marrow — the spongy tissue inside bones where blood cells are produced — by generating reactive metabolites that cause DNA strand breaks and chromosomal abnormalities.
TCE and PCE contribute through a different but overlapping mechanism. These solvents are metabolized into reactive intermediates that interfere with hematopoiesis, the process of blood cell production. Chronic exposure can lead to clonal expansion of abnormal white blood cells — the hallmark of leukemia.
A 2014 ATSDR mortality study found that Camp Lejeune Marines had a 10% higher risk of dying from all cancers combined compared to Marines stationed at Camp Pendleton (a control group). For specific cancers like kidney cancer and leukemia, the risk ratios were even more striking.
Which Types of Leukemia Are Linked to Camp Lejeune?
Not all leukemias carry the same association. The types most strongly connected to VOC exposure include:
- Acute myeloid leukemia (AML) — the type most clearly tied to benzene exposure, often appearing years or decades after initial contact
- Acute lymphoblastic leukemia (ALL) — seen in some children born to families stationed at the base
- Chronic lymphocytic leukemia (CLL) — the most common adult leukemia, with growing evidence of environmental links
- Myelodysplastic syndromes (MDS) — a pre-leukemic condition that frequently progresses to AML
The latency period between exposure and diagnosis can be 5 to 40+ years, which is why veterans are still being diagnosed with leukemia today from exposures that ended in 1987.
Symptoms That Should Prompt Evaluation
Leukemia symptoms are notoriously vague in their early stages, which is part of what makes this disease so dangerous. If you have a history of Camp Lejeune exposure, pay attention to:
- Persistent fatigue that doesn’t improve with rest
- Unexplained bruising or petechiae (tiny red dots on the skin)
- Recurrent infections or fevers without a clear cause
- Unintentional weight loss
- Bone pain, especially in the sternum or long bones
- Pale skin, shortness of breath, or dizziness (signs of anemia)
- Swollen lymph nodes, liver, or spleen
Any of these in isolation might be nothing. Several of them together — especially with a history of toxic exposure — warrant a complete blood count (CBC) and a referral to hematology.
Diagnosis: What Tests Will Your Doctor Order?
A CBC with differential is the starting point. Abnormal findings might include elevated or severely low white blood cell counts, low platelets (thrombocytopenia), or low hemoglobin. If results are suspicious, the next steps typically include:
- Peripheral blood smear — a pathologist examines blood cells under a microscope looking for blasts (immature cells)
- Bone marrow biopsy — the definitive test, where a sample is taken from the hip bone to evaluate marrow cellularity and blast percentage
- Flow cytometry — identifies cell surface markers to classify the exact leukemia subtype
- Cytogenetic analysis and FISH — detects chromosomal abnormalities like the Philadelphia chromosome (t(9;22)) or deletions that guide treatment
- Molecular testing (PCR/NGS) — screens for mutations in genes like FLT3, NPM1, TP53, and IDH1/2 that affect prognosis and therapy selection
Treatment Options for Camp Lejeune-Related Leukemia
Treatment depends entirely on the leukemia subtype, the patient’s age and fitness level, and the molecular profile of the disease. There’s no single “Camp Lejeune leukemia treatment” — the cancer is treated based on its biology, not its cause.
That said, common treatment approaches include:
- Induction chemotherapy — the standard first-line approach for AML (typically cytarabine + daunorubicin, known as “7+3”)
- Targeted therapy — drugs like midostaurin (for FLT3-mutated AML) or venetoclax (for CLL and older AML patients)
- Stem cell transplant — potentially curative for eligible patients with high-risk disease
- Watchful waiting — appropriate for early-stage CLL that isn’t causing symptoms
- Immunotherapy — including CAR-T cell therapy for relapsed ALL
Your Legal Rights Under the Camp Lejeune Justice Act
The Camp Lejeune Justice Act, signed into law on August 10, 2022, as part of the PACT Act, allows veterans, family members, and civilian workers who were exposed to contaminated water for at least 30 days between August 1953 and December 1987 to file claims against the federal government. Leukemia is one of the presumptive conditions recognized by the VA for Camp Lejeune exposure.
This means if you have a qualifying diagnosis, you don’t have to prove the water caused your cancer — the government presumes the connection. Claims are filed through the U.S. District Court for the Eastern District of North Carolina.
Frequently Asked Questions
How long after Camp Lejeune exposure can leukemia develop?
Leukemia can develop anywhere from 5 to 40+ years after exposure to carcinogenic chemicals. Many veterans are being diagnosed now, decades after their service at the base ended. Benzene-related AML typically has a latency of 5–15 years, but longer intervals have been documented.
Does the VA automatically cover leukemia treatment for Camp Lejeune veterans?
Yes. The VA provides healthcare benefits for 15 specific conditions linked to Camp Lejeune water contamination, and leukemia is among them. You need to have served or resided at Camp Lejeune for at least 30 days during the contamination period. Enroll through VA healthcare and mention your Camp Lejeune exposure history.
Can family members who lived on base also file claims?
Absolutely. The Camp Lejeune Justice Act covers not just service members but also their dependents — spouses and children who lived on the base and drank the contaminated water. Tragically, some children developed leukemia in childhood from in-utero or early-life exposure.
What if I was at Camp Lejeune but haven’t been diagnosed with leukemia yet?
Talk to your primary care doctor about your exposure history and request baseline blood work (CBC with differential) annually. Report any symptoms like unexplained fatigue, bruising, or recurrent infections promptly. Early detection significantly improves leukemia outcomes.
Is there a deadline to file a Camp Lejeune claim?
Yes. Under the Camp Lejeune Justice Act, claims must generally be filed within two years of the law’s enactment — meaning the window closes in August 2024. However, legal timelines can shift, so consult an attorney experienced in Camp Lejeune cases as soon as possible.
When to See a Doctor
If you lived or worked at Camp Lejeune between 1953 and 1987 — even briefly — and you’re experiencing unexplained fatigue, easy bruising, recurrent infections, or bone pain, schedule an appointment with your doctor now. Ask specifically for a CBC with differential and peripheral smear. Make sure your medical record documents your Camp Lejeune exposure history, as this matters for both clinical decision-making and VA benefits.
Don’t wait for symptoms to worsen. Leukemia caught in its earlier stages has meaningfully better outcomes, and you’ve already earned the right to comprehensive care.
